Telesis Bio Reports First Quarter 2024 Financial Results

Net loss was $8.6 million for the first quarter of 2024, compared to a loss of $11.1 million in the same period in the prior year. Net loss per share was $5.52 ...

Quarterly Results - Telesis Bio

Q1. Telesis Bio Reports First Quarter 2024 Financial Results · Form 10-Q. 2023. Q4. Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results.

Telesis Bio Reports First Quarter 2024 Financial Results ; 2024 ; Revenue: Product sales ; Product sales, $, 1,264 ; Service revenue, 1,251 ...

Telesis Bio: Investors

August 7, 2024. Telesis Bio Reports Second Quarter and First Half 2024 Financial Results · View All News. Events. May 1, 2024 8:00 AM PDT. 2024 Annual ...

Telesis Bio Reports Second Quarter and First Half 2024 Financial ...

Telesis Bio Reports Second Quarter and First Half 2024 Financial Results ; Total revenue, 1,550 ; Cost of revenue, 2,349 ; Gross Profit, (799, ) ...

Telesis Bio Reports Second Quarter and First Half 2024 Financial ...

Telesis Bio reports Q2 2024 results: Revenue down 77%, net loss widens to $13.2M. Despite challenges, company advances Gibson SOLA platform ...

Form 8-K for Telesis BIO INC filed 05/09/2024

Telesis Bio Reports First Quarter 2024 Financial Results. May 9, 2024. SAN DIEGO, May 9, 2024 (GLOBE NEWSWIRE) – Telesis Bio Inc. (NASDAQ ...

Telesis Bio Reports Second Quarter and First Half 2024

Telesis Bio Reports Second Quarter and First Half 2024 Financial Results ; Cash, restricted cash, cash equivalents and short-term investments, $ ...

EX-99.1 - SEC.gov

Telesis Bio Reports First Quarter 2023 Financial Results. -- Total revenue of $6.3M in 1QFY23. -- BioXp® franchise revenue increased by 28%. SAN DIEGO, May 11 ...

News Releases | Telesis Bio

... Biofoundry Capabilities SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A ... May 9, 2024. Telesis Bio Reports First Quarter 2024 Financial Results. SAN ...

BeiGene Reports First Quarter 2024 Financial Results and Business ...

The increase in product revenue was attributable to increased sales of our internally developed products, BRUKINSA and tislelizumab. For the three months ended ...

Akoya Biosciences Reports First Quarter 2024 Financial Results

Revenue was $18.4 million in the first quarter of 2024, compared to $21.4 million in the prior year period; a decrease of 14%. Reagents and services revenue ...

Annual Report + Proxy - Telesis Bio

We are pleased to invite you to attend the 2024 Annual Meeting of Stockholders (the Annual Meeting) of Telesis Bio Inc. (Telesis Bio or the Company), ...

Telesis Bio to Report First Quarter Financial Results on Thursday ...

Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its first quarter 2023 ...

Telesis Bio to Report First Quarter Financial Results on Thursday ...

SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, ...

Bioventus Reports First Quarter Financial Results

Includes for the three months ended March 30, 2024 and April 1, 2023, respectively, depreciation and amortization of $10,025 and $14,339 in cost of sales and ...

Telesis Bio Inc. (TBIO) Quarterly 10-Q Report - Quartz

The filing details a decrease in total revenue to $5.3 million for the nine months ended September 30, 2024, from $15.8 million in the same ...

Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial ...

Revenue: The Company expects to report revenue for the fourth quarter of 2022 of $9 million compared to $3 million for the for the same period ...

Telesis Bio Reports Second Quarter 2023 Financial Results

Telesis Bio Inc., a leader in automated multi-omic and synthetic biology solutions, reported financial results for the second quarter of 2023.

Cytek Biosciences Reports First Quarter 2024 Financial Results

Total revenue for the first quarter of 2024 was $44.9 million, a 21% increase over the first quarter of 2023. Excluding the $7.6 million of revenue from the ...